abstract |
Abstract The invention relates to novel linear peptides of the formula I X-A-B-C-Arg-E-G-L-Z I, in which A, B, C, E, G, L, X and Z have the meaning indicated in Claim 1, and their salts. These compounds act as integrin inhibitors and can be used in particular for the prophylaxis and treatment of disorders of the circulation and for tumour therapy. |